| Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance NA Terrault, ASF Lok, BJ McMahon, KM Chang, JP Hwang, MM Jonas, ... Hepatology 67 (4), 1560-1599, 2018 | 3792 | 2018 |
| A ASLD guidelines for treatment of chronic hepatitis B NA Terrault, NH Bzowej, KM Chang, JP Hwang, MM Jonas, MH Murad Hepatology 63 (1), 261-283, 2016 | 2333 | 2016 |
| Determinants of viral clearance and persistence during acute hepatitis C virus infection R Thimme, D Oldach, KM Chang, C Steiger, SC Ray, FV Chisari The Journal of experimental medicine 194 (10), 1395-1406, 2001 | 1524 | 2001 |
| Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria GF Sonnenberg, LA Monticelli, T Alenghat, TC Fung, NA Hutnick, ... Science 336 (6086), 1321-1325, 2012 | 793 | 2012 |
| Genetics of blood lipids among~ 300,000 multi-ethnic participants of the Million Veteran Program D Klarin, SM Damrauer, K Cho, YV Sun, TM Teslovich, J Honerlaw, ... Nature genetics 50 (11), 1514-1523, 2018 | 555 | 2018 |
| Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis M Vujkovic, JM Keaton, JA Lynch, DR Miller, J Zhou, C Tcheandjieu, ... Nature genetics 52 (7), 680-691, 2020 | 510 | 2020 |
| Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection K Sugimoto, F Ikeda, J Stadanlick, FA Nunes, HJ Alter, KM Chang Hepatology 38 (6), 1437-1448, 2003 | 495 | 2003 |
| Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade N Nakamoto, H Cho, A Shaked, K Olthoff, ME Valiga, M Kaminski, ... PLoS pathogens 5 (2), e1000313, 2009 | 460 | 2009 |
| Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection KM Chang, R Thimme, JJ Melpolder, D Oldach, J Pemberton, ... Hepatology 33 (1), 267-276, 2001 | 454 | 2001 |
| Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. KM Chang, B Rehermann, JG McHutchison, C Pasquinelli, S Southwood, ... The Journal of clinical investigation 100 (9), 2376-2385, 1997 | 419 | 1997 |
| A global scientific strategy to cure hepatitis B PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ... The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019 | 418 | 2019 |
| The power of genetic diversity in genome-wide association studies of lipids SE Graham, SL Clarke, KHH Wu, S Kanoni, GJM Zajac, S Ramdas, ... Nature 600 (7890), 675-679, 2021 | 392 | 2021 |
| Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. B Rehermann, KM Chang, JG McHutchison, R Kokka, M Houghton, ... The Journal of clinical investigation 98 (6), 1432-1440, 1996 | 366 | 1996 |
| Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization N Nakamoto, DE Kaplan, J Coleclough, Y Li, ME Valiga, M Kaminski, ... Gastroenterology 134 (7), 1927-1937. e2, 2008 | 360 | 2008 |
| Present and future therapies of hepatitis B: from discovery to cure TJ Liang, TM Block, BJ McMahon, MG Ghany, S Urban, JT Guo, ... Hepatology 62 (6), 1893-1908, 2015 | 340 | 2015 |
| Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients B Rehermann, KM Chang, J McHutchinson, R Kokka, M Houghton, ... Journal of Virology 70 (10), 7092-7102, 1996 | 338 | 1996 |
| Different affinity windows for virus and cancer‐specific T‐cell receptors: implications for therapeutic strategies M Aleksic, N Liddy, PE Molloy, N Pumphrey, A Vuidepot, KM Chang, ... European journal of immunology 42 (12), 3174-3179, 2012 | 295 | 2012 |
| Guidance for design and endpoints of clinical trials in chronic hepatitis B—report from the 2019 EASL‐AASLD HBV Treatment Endpoints Conference M Cornberg, ASF Lok, NA Terrault, F Zoulim, ... Hepatology 71 (3), 1070-1092, 2020 | 279 | 2020 |
| Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells B Bengsch, T Ohtani, O Khan, M Setty, S Manne, S O’Brien, PF Gherardini, ... Immunity 48 (5), 1029-1045. e5, 2018 | 279 | 2018 |
| Hepatitis C virus: virology and life cycle CW Kim, KM Chang Clinical and molecular hepatology 19 (1), 17, 2013 | 268 | 2013 |
